Raviender Bukkapatnam, MD
Payments from drug & device makers
Across 756 payments — averaging $320.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$134K
- Janssen Research & Development, LLC$35K
- Axonics, Inc.$16K
- Palette Life Sciences, Inc.$16K
- Ferring Pharmaceuticals AS$14K
- Intuitive Surgical$10K
- plus $18K from 54 others
Across 1 payment — averaging $532.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$533
What the payments were for
- Consulting fees$54,06747%
- Speaking & faculty fees$32,22228%
- Travel & lodging$5,3955%
- Food & beverage$18,30016%
- Education$5,0094%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTERSTIM$53,986
- Deflux$15,900
- Axonics r-SNM System$11,976
- Da Vinci Surgical System$8,067
- NURO$2,058
- DA VINCI SP$1,500
- PROVENGE$1,325
- Bulkamid$1,065
- SpaceOAR System$897
- TRELSTAR$829
- Signia$271
- Natesto$222
- SpaceOAR VUE System - 10mL$175
- AQUABEAM SYSTEM$149
- eCoin Device Kit$147
- AMS 700 CXR RTE KIT$140
- INFINITY OCCIPITOCERVICAL UPPER THORACIC SYSTEM$125
- GENERAL BPH$122
- INTERSTIM ICON$121
- LithoVue$111
How this compares
$242,494 in reported general payments places this provider in the 95th percentile of 935 urology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 240 | $211,473 |
| Thiola EcTiopronin | 16 | $159,486 |
| GemtesaVibegron | 89 | $96,973 |
| Methenamine Hippurate | 267 | $24,573 |
| Mirabegron ErMirabegron | 16 | $15,095 |
| Solifenacin Succinate | 161 | $7,243 |
| Tamsulosin Hcl | 465 | $6,078 |
| Testosterone | 28 | $6,007 |
| FirmagonDegarelix Acetate | 12 | $5,874 |
| Testosterone Cypionate | 84 | $4,598 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 44 | $3,956 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 61 | $3,102 |
| Dutasteride | 75 | $2,731 |
| Potassium Citrate ErPotassium Citrate | 20 | $2,341 |
| Trimethoprim | 37 | $2,204 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $452 | $211,473240 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $3,709 | $96,97389 claims |
| Ferring Pharmaceuticals Inc.Firmagon | $56 | $5,87412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 935 urology providers in Florida.
Other urology in Tampa
- Osvaldo PadronTampa$1.3M
- Rafael CarrionTampa$445K
- Richard BrunelleTampa$357K
- Philippe SpiessTampa$304K
- Alice YuTampa$181K
- David HernandezTampa$162K
- Steven KesterPompano Beach$5.7M
- Harvey SamowitzHallandale Beach$3.6M
- Paul PeritoCoral Gables$3.6M
- Graham GreeneLakeland$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.